查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593749

支架市场评估：按产品类型、支架类型、材料、类型、最终用户和地区划分的机会和预测（2017-2031）

Stents Market Assessment, By Product Type, By Stent Type, By Material, By Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 229 Pages | 商品交期: 3-5个工作天内

价格

全球支架市场规模预计将从 2023 年的 126.9 亿美元成长到 2031 年的 203.1 亿美元，预测期内复合年增长率为 6.05%。

该市场的成长得益于心血管疾病和病症病例数量的增加、参与公司加大力度推出新产品、老年人口的扩大以及支架设计技术的进步。

新支架的推出可以避免一系列以前被认为不可避免的心臟手术，这为市场创造了利润丰厚的成长机会。 2024年10月，FDA批准了一款专为婴幼儿设计的支架，帮助患有先天性心臟病的儿童避免进行心臟直视手术。通常，当婴儿或婴幼儿需要支架时，外科医生会修改或截断成人大小的支架，并将其推入婴儿心臟中的核桃大小的血管中。这种方法并不理想，因为随着孩子长大，血管变大，必须透过心臟直视手术更换支架。 RENATA MEDICAL 的 Minima 支架旨在与您的孩子一起成长，无需手术。 FDA 也批准其用于治疗两种心臟疾病：主动脉狭窄和缩窄。

随着生活方式的改变和人口老化的加剧，世界不同地区心臟病的发生率不断增加，对支架市场的扩张产生了积极影响。

本报告调查了全球支架市场，提供市场定义和概述、市场规模趋势和预测、各个细分市场/地区/主要国家的详细分析、行业结构以及影响市场成长的因素分析、案例研究、竞争格局。

目录

第一章专案范围与定义

第二章研究方法

第 3 章执行摘要

第四章全球支架市场展望

  • 市场规模分析与预测
  • 市占率分析/预测
    • 依产品类型
    • 按支架类型
    • 依材质
    • 依类型
    • 按最终用户
    • 按地区
    • 按公司划分的市占率分析
  • 市场地图分析

第五章北美支架市场展望

  • 市场规模分析与预测
  • 市占率分析/预测
  • 国家市场评估
    • 美国
    • 加拿大
    • 墨西哥

第六章欧洲支架市场展望

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 土耳其
  • 波兰

第七章亚太支架市场展望

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第八章南美洲支架市场展望

  • 巴西
  • 阿根廷

第九章中东及非洲支架市场展望

  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第10章供需分析

第 11 章汇入/汇出分析

第十二章价值链分析

第 13 章波特五力分析

第14章PESTLE分析

第十五章价格分析

第 16 章市场动态

  • 市场驱动因素
  • 市场课题

第十七章市场趋势与发展

第 18 章法律与监管架构/创新

  • 临床试验
  • 监理机关的核准

第十九章专利状况

第 20 章个案研究

第21章竞争态势

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名的公司的 SWOT 分析
  • 前10名企业状况
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • B. Braun SE
    • BIOTRONIK SE & Co. KG
    • Terumo Group
    • Biosensors International Group, Ltd.
    • Stryker Corporation
    • MicroPort Scientific Corporation
    • Cook Group Incorporated

第 22 章策略建议

第23章关于我们公司/免责声明

Product Code: MX12261

Global stents market is projected to witness a CAGR of 6.05% during the forecast period 2024-2031, growing from USD 12.69 billion in 2023 to USD 20.31 billion in 2031. The market's growth is supported by the rising cases of cardiovascular diseases and disorders, increasing efforts by the market players to introduce novel products, expansion of the geriatric population, and technological advancements in stent design. Small mesh-like devices are inserted in veins and arteries to keep them open and allow unrestricted fluid and blood flow. Stents are commonly used for treating conditions such as peripheral artery disease and coronary artery disease, among other blockages that can often result in life-threatening complications.

The introduction of new stents to avoid a series of heart operations that were previously considered unavoidable is providing lucrative growth opportunities for the market. In October 2024, the Food and Drug Administration (FDA) approved a stent designed specifically for young children and infants to aid kids born with congenital heart defects in avoiding a series of open-heart operations. Usually, when young children and infants require stents, surgeons modify or trim adult-size stents and squeeze them into the vessels of the infants' hearts, which are approximately the size of a walnut. This method was not ideal as when the child grows older, their blood vessels get bigger, leading to the stents getting replaced in an open-heart surgery. The Minima stent, produced by RENATA MEDICAL, is designed to grow as the child grows, eliminating the surgery requirement. The FDA has also approved it for treating two heart conditions, i.e., stenosis and coarctation.

With increasing lifestyle changes and the growth of the aging population, the occurrence of heart diseases is increasing in different regions across the globe, positively influencing the expansion of the stents market.

Expansion of Geriatric Population to Boost Market Demand

The rapid growth of the aging population is one of the major factors augmenting the requirement for stents from different regions across the globe. As per the estimates of the World Health Organization (WHO), approximately 17.9 million individuals across the globe die from cardiovascular diseases every year. Aging increases the risk of cardiovascular diseases, such as coronary artery disease, atherosclerosis, and hypertension, propelling the requirement for medical intervention and equipment for effective management of heart-related issues. Due to the minimally invasive nature of stenting procedures, they are preferred for older patients who might not be suitable for open heart surgeries due to various age-related complications. Coronary stenting is usually preferred for older people as it allows faster recovery of patients, shorter hospital stays, and minimally invasive alternatives to open heart procedures. The surgical procedures become risky with age, especially if the patients are suffering from coronary artery disease, along with other chronic conditions such as high blood pressure and diabetes. Thus, minimally invasive procedures, including stenting and coronary angioplasty, are more beneficial in elderly patients.

Increasing Investments to Support Market Expansion

The continuous innovations and technological advancements in stent design and manufacturing are providing lucrative growth opportunities to the global stents market. Various medical device companies are actively working on raising investments to propel the development of novel treatment solutions for different cardiac conditions. In February 2024, CeroFlo, an Irish medical device company, announced that they had raised approximately USD 6.9 million (EUR 6.4 million) in investment round funding to advance the development of their novel stent, SubMax device, intended to revolutionize intracranial atherosclerotic disease treatments. The company announced that the funds will aid them in supporting first-in-human clinical trials across thirty patients. Such investments are expected to propel the development and availability of novel technologies, providing lucrative growth opportunities to the market.

Additionally, increasing investments are aiding the leading medical device companies in producing stents that are compatible with the complex anatomical structure of the heart, allowing healthcare professionals to provide customized treatments for patients with varying requirements.

Coronary Stenting to Account for a Significant Market Share

The rising investments by medical device companies in research and development activities for coronary stents are supporting the segment's expansion. The increasing efforts by the leading market players to ensure the availability of coronary stent systems in different regions across the globe are boosting the segment's growth. Additionally, the growing research activities for managing coronary artery perforations further aid the segment's growth. Research institutions across the globe are working on developing a bioresorbable polymer membrane to seal coronary artery perforations effectively. Such coatings could effectively correct symptomatic aneurysms and mitigate neointimal hyperplasia in the vascular lumen.

Coronary stents, including drug-eluting stunts, are increasingly being deployed to treat narrowed or blocked arteries caused by plaque buildup. Additionally, the minimally invasive nature of coronary stenting is bolstering its adoption and providing lucrative growth opportunities to the market. The shorter recovery time, lower risk of complications, and reduced hospital stays associated with the stenting procedure drive the market's demand.

North America to Hold Major Market Share

The increasing awareness among the general population about cardiovascular health, the presence of well-established healthcare infrastructure, and the expansion of the geriatric population are some of the major factors bolstering the growth of the North America stents market. The rising cases of cardiovascular diseases are propelling the market's expansion. According to the estimates by the US Centers for Disease Control and Prevention, 702,880 individuals died from heart disease in 2022. Additionally, the increasing efforts by key market players and research organizations boost the development of innovative devices for different cardiac conditions, providing lucrative growth opportunities to the market.

Meanwhile, the Asia-Pacific market is expected to witness significant growth over the forecast period as an increasing number of patients undergo stenting procedures in countries such as Japan, India, and China due to the expansion of insurance coverage and accessibility to affordable healthcare solutions. Furthermore, the rising awareness about heart health and the importance of regular health checkups and early treatments is propelling the demand for stenting procedures in the region. To meet the rising requirements, local manufacturers are stepping up and producing cost-effective options to increase the accessibility of the procedure for a wider population base.

Future Market Scenario (2024-2031F)

The market is expected to witness significant growth in the forecast years due to the increasing prevalence of cardiovascular diseases, rising partnerships between leading healthcare companies, and growing emphasis on innovation and novel product development. The growing awareness about cardiovascular health and the rapid expansion of the geriatric population is expected to provide lucrative growth opportunities for the market. As per the estimates of the WHO, one in six people across the globe will be 60 years or older by 2030.

Additionally, the market is expected to witness significant growth as different emerging economies, such as South America and Asia-Pacific, invest in improving their healthcare infrastructure. The key market players are expected to increasingly invest in producing more effective and safer stents, improving their designs to cater to the specific requirements of the patient population. The rising emphasis on minimally invasive treatments, in combination with rapid innovations in stent technology, is expected to positively influence the market's expansion.

Key Players Landscape and Outlook

The key players in the market are investing in introducing newer products to expand their market share. In May 2024, Abbott introduced the new generation of XIENCE Sierra Everolimus drug-eluting coronary stent system in India. XIENCE stents are effective in cases of narrow and difficult-to-treat lesions and chronic cases. The improved deliverability and innovative design allow physicians to unblock difficult-to-treat lesions with precision and flexibility. The product contains a highly specialized coating that decreases the probability of arteries re-blocking.

Additionally, the market players are receiving approval from different regulatory bodies, allowing them to distribute their products across the globe and aiding them in expanding their market share. In April 2022, Biosensors International Group, Ltd. announced that they received approval for BioFreedom from the United States FDA and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The BioFreedom stent systems optimize the percutaneous coronary intervention (PCI) procedure for patients with high bleeding risk by simplifying stent choice prior to the procedure. Such approvals are aiding the market players in expanding their global footprint and positively influencing the expansion of the global stents market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Stents Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Coronary Stenting
      • 4.2.1.2. Peripheral Stenting
    • 4.2.2. By Stent Type
      • 4.2.2.1. Bare-Metal Stents
      • 4.2.2.2. Drug-Eluting Stents
      • 4.2.2.3. Bioabsorbable Stents
      • 4.2.2.4. Others
    • 4.2.3. By Material
      • 4.2.3.1. Metallic Stents
      • 4.2.3.2. Non-Metallic Stents
    • 4.2.4. By Type
      • 4.2.4.1. Self-Expanding Stents
      • 4.2.4.2. Balloon-Expanding Stents
    • 4.2.5. By End-user
      • 4.2.5.1. Hospitals
      • 4.2.5.2. Ambulatory Care Centers (ACS)
      • 4.2.5.3. Specialty Clinics
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia-Pacific
      • 4.2.6.4. South America
      • 4.2.6.5. Middle East and Africa
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product Type
    • 4.3.2. By Stent Type
    • 4.3.3. By Material
    • 4.3.4. By Type
    • 4.3.5. By End-user
    • 4.3.6. By Region

5. North America Stents Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. Coronary Stenting
      • 5.2.1.2. Peripheral Stenting
    • 5.2.2. By Stent Type
      • 5.2.2.1. Bare-Metal Stents
      • 5.2.2.2. Drug-Eluting Stents
      • 5.2.2.3. Bioabsorbable Stents
      • 5.2.2.4. Others
    • 5.2.3. By Material
      • 5.2.3.1. Metallic Stents
      • 5.2.3.2. Non-Metallic Stents
    • 5.2.4. By Type
      • 5.2.4.1. Self-Expanding Stents
      • 5.2.4.2. Balloon-Expanding Stents
    • 5.2.5. By End-user
      • 5.2.5.1. Hospitals
      • 5.2.5.2. Ambulatory Care Centers (ACS)
      • 5.2.5.3. Specialty Clinics
    • 5.2.6. By Country Share
      • 5.2.6.1. United States
      • 5.2.6.2. Canada
      • 5.2.6.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Stents Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product Type
          • 5.3.1.2.1.1. Coronary Stenting
          • 5.3.1.2.1.2. Peripheral Stenting
        • 5.3.1.2.2. By Stent Type
          • 5.3.1.2.2.1. Bare-Metal Stents
          • 5.3.1.2.2.2. Drug-Eluting Stents
          • 5.3.1.2.2.3. Bioabsorbable Stents
          • 5.3.1.2.2.4. Others
        • 5.3.1.2.3. By Material
          • 5.3.1.2.3.1. Metallic Stents
          • 5.3.1.2.3.2. Non-Metallic Stents
        • 5.3.1.2.4. By Type
          • 5.3.1.2.4.1. Self-Expanding Stents
          • 5.3.1.2.4.2. Balloon-Expanding Stents
        • 5.3.1.2.5. By End-user
          • 5.3.1.2.5.1. Hospitals
          • 5.3.1.2.5.2. Ambulatory Care Centers (ACS)
          • 5.3.1.2.5.3. Specialty Clinics
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Stents Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Stents Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Stents Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Stents Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Medtronic plc
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Boston Scientific Corporation
    • 21.3.3. Abbott Laboratories
    • 21.3.4. B. Braun SE
    • 21.3.5. BIOTRONIK SE & Co. KG
    • 21.3.6. Terumo Group
    • 21.3.7. Biosensors International Group, Ltd.
    • 21.3.8. Stryker Corporation
    • 21.3.9. MicroPort Scientific Corporation
    • 21.3.10. Cook Group Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 3. Global Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 4. Global Stents Market Share (%), By Material, 2017-2031F
  • Figure 5. Global Stents Market Share (%), By Type, 2017-2031F
  • Figure 6. Global Stents Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Stents Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 11. North America Stents Market Share (%), By Material, 2017-2031F
  • Figure 12. North America Stents Market Share (%), By Type, 2017-2031F
  • Figure 13. North America Stents Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Stents Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 17. United States Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 18. United States Stents Market Share (%), By Material, 2017-2031F
  • Figure 19. United States Stents Market Share (%), By Type, 2017-2031F
  • Figure 20. United States Stents Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 23. Canada Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 24. Canada Stents Market Share (%), By Material, 2017-2031F
  • Figure 25. Canada Stents Market Share (%), By Type, 2017-2031F
  • Figure 26. Canada Stents Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 29. Mexico Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 30. Mexico Stents Market Share (%), By Material, 2017-2031F
  • Figure 31. Mexico Stents Market Share (%), By Type, 2017-2031F
  • Figure 32. Mexico Stents Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 35. Europe Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 36. Europe Stents Market Share (%), By Material, 2017-2031F
  • Figure 37. Europe Stents Market Share (%), By Type, 2017-2031F
  • Figure 38. Europe Stents Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Stents Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 42. Germany Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 43. Germany Stents Market Share (%), By Material, 2017-2031F
  • Figure 44. Germany Stents Market Share (%), By Type, 2017-2031F
  • Figure 45. Germany Stents Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 48. France Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 49. France Stents Market Share (%), By Material, 2017-2031F
  • Figure 50. France Stents Market Share (%), By Type, 2017-2031F
  • Figure 51. France Stents Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 54. Italy Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 55. Italy Stents Market Share (%), By Material, 2017-2031F
  • Figure 56. Italy Stents Market Share (%), By Type, 2017-2031F
  • Figure 57. Italy Stents Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 60. United Kingdom Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 61. United Kingdom Stents Market Share (%), By Material, 2017-2031F
  • Figure 62. United Kingdom Stents Market Share (%), By Type, 2017-2031F
  • Figure 63. United Kingdom Stents Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 66. Russia Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 67. Russia Stents Market Share (%), By Material, 2017-2031F
  • Figure 68. Russia Stents Market Share (%), By Type, 2017-2031F
  • Figure 69. Russia Stents Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Netherlands Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 73. Netherlands Stents Market Share (%), By Material, 2017-2031F
  • Figure 74. Netherlands Stents Market Share (%), By Type, 2017-2031F
  • Figure 75. Netherlands Stents Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 78. Spain Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 79. Spain Stents Market Share (%), By Material, 2017-2031F
  • Figure 80. Spain Stents Market Share (%), By Type, 2017-2031F
  • Figure 81. Spain Stents Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 84. Turkey Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 85. Turkey Stents Market Share (%), By Material, 2017-2031F
  • Figure 86. Turkey Stents Market Share (%), By Type, 2017-2031F
  • Figure 87. Turkey Stents Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 90. Poland Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 91. Poland Stents Market Share (%), By Material, 2017-2031F
  • Figure 92. Poland Stents Market Share (%), By Type, 2017-2031F
  • Figure 93. Poland Stents Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 96. South America Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 97. South America Stents Market Share (%), By Material, 2017-2031F
  • Figure 98. South America Stents Market Share (%), By Type, 2017-2031F
  • Figure 99. South America Stents Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Stents Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 103. Brazil Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 104. Brazil Stents Market Share (%), By Material, 2017-2031F
  • Figure 105. Brazil Stents Market Share (%), By Type, 2017-2031F
  • Figure 106. Brazil Stents Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 109. Argentina Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 110. Argentina Stents Market Share (%), By Material, 2017-2031F
  • Figure 111. Argentina Stents Market Share (%), By Type, 2017-2031F
  • Figure 112. Argentina Stents Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 115. Asia-Pacific Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 116. Asia-Pacific Stents Market Share (%), By Material, 2017-2031F
  • Figure 117. Asia-Pacific Stents Market Share (%), By Type, 2017-2031F
  • Figure 118. Asia-Pacific Stents Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Stents Market Share (%), By Country, 2017-2031F
  • Figure 120. India Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 122. India Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 123. India Stents Market Share (%), By Material, 2017-2031F
  • Figure 124. India Stents Market Share (%), By Type, 2017-2031F
  • Figure 125. India Stents Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 128. China Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 129. China Stents Market Share (%), By Material, 2017-2031F
  • Figure 130. China Stents Market Share (%), By Type, 2017-2031F
  • Figure 131. China Stents Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Japan Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 135. Japan Stents Market Share (%), By Material, 2017-2031F
  • Figure 136. Japan Stents Market Share (%), By Type, 2017-2031F
  • Figure 137. Japan Stents Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 140. Australia Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 141. Australia Stents Market Share (%), By Material, 2017-2031F
  • Figure 142. Australia Stents Market Share (%), By Type, 2017-2031F
  • Figure 143. Australia Stents Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 146. Vietnam Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 147. Vietnam Stents Market Share (%), By Material, 2017-2031F
  • Figure 148. Vietnam Stents Market Share (%), By Type, 2017-2031F
  • Figure 149. Vietnam Stents Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 152. South Korea Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 153. South Korea Stents Market Share (%), By Material, 2017-2031F
  • Figure 154. South Korea Stents Market Share (%), By Type, 2017-2031F
  • Figure 155. South Korea Stents Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 158. Indonesia Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 159. Indonesia Stents Market Share (%), By Material, 2017-2031F
  • Figure 160. Indonesia Stents Market Share (%), By Type, 2017-2031F
  • Figure 161. Indonesia Stents Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 164. Philippines Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 165. Philippines Stents Market Share (%), By Material, 2017-2031F
  • Figure 166. Philippines Stents Market Share (%), By Type, 2017-2031F
  • Figure 167. Philippines Stents Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 170. Middle East & Africa Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 171. Middle East & Africa Stents Market Share (%), By Material, 2017-2031F
  • Figure 172. Middle East & Africa Stents Market Share (%), By Type, 2017-2031F
  • Figure 173. Middle East & Africa Stents Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Stents Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 177. Saudi Arabia Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 178. Saudi Arabia Stents Market Share (%), By Material, 2017-2031F
  • Figure 179. Saudi Arabia Stents Market Share (%), By Type, 2017-2031F
  • Figure 180. Saudi Arabia Stents Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 183. UAE Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 184. UAE Stents Market Share (%), By Material, 2017-2031F
  • Figure 185. UAE Stents Market Share (%), By Type, 2017-2031F
  • Figure 186. UAE Stents Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Stents Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Stents Market Share (%), By Product Type, 2017-2031F
  • Figure 189. South Africa Stents Market Share (%), By Stent Type, 2017-2031F
  • Figure 190. South Africa Stents Market Share (%), By Material, 2017-2031F
  • Figure 191. South Africa Stents Market Share (%), By Type, 2017-2031F
  • Figure 192. South Africa Stents Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Stent Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Material Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023